OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)
RegisteredCombined Mark
•
Ownership
BS
Owner Name
Type: Organization / Corporation
Address
Route 206 & Province Line Road
Princeton, NJ 08543
Critical Dates
First Use Date
Mar 22, 2022
Filing Date
Apr 1, 2022
Registration Date
Aug 8, 2023
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for human use comprising monoclonal antibodies for the treatment and prevention of cancer
Mark Elements
Text Mark
OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description
The mark consists of the term "OPDUALAG" in blue with a curved line over it in light blue and yellow and the term "(NIVOLUMAB AND RELATLIMAB-RMBW)" in blue below it.
Color Details
The color(s) Blue, Light Blue and Yellow is/are claimed as a feature of the mark.
Design Search Codes
26.17.09
Bands, curvedData source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI Assessment
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
No summary available
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach